Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo, exercise is not a strict requirement for Wegovy to work. Semaglutide acts on appetite and satiety through GLP-1 receptors, and the clinical trials that earned it UK approval enrolled participants following a reduced-calorie diet with only broadly encouraged physical activity, not a prescribed training programme. That said, the evidence is equally clear that adding movement meaningfully improves what treatment can do for you, and the NHS patient guidance for semaglutide recommends combining it with diet and activity for best outcomes. Wegovy is a prescription-only medicine; a GPhC-registered prescriber reviews whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That question comes up a lot in the early weeks. There's a common assumption that weight-loss medicines only work if you're simultaneously overhauling your fitness routine, and it can feel like a judgment call, as if not joining a gym somehow undermines the prescription. That assumption is worth letting go. The NICE appraisal of semaglutide (TA875) recommended Wegovy for adults meeting the relevant eligibility criteria based on trial data where the activity component was an encouragement, not a controlled exercise intervention. Participants were advised to move more and eat less, not to hit a step count or attend classes. The medicine's mechanism does the heavy lifting on appetite suppression regardless. So if you're not exercising at all right now, Wegovy can still work, and if you want a clear answer to whether you actually need to exercise on Wegovy, that question is explored in detail on its own page. The more honest message is that movement changes what that weight loss looks like, and that distinction matters.
If you want to understand how semaglutide interacts with physical performance more broadly, there's a detailed look at exercising on semaglutide covering energy levels, timing, and what to expect in the early titration weeks.
When the body loses weight, it does not strip fat alone. Lean muscle is lost too, and this is one of the more under-discussed consequences of rapid weight reduction, whether from dieting, surgery, or GLP-1 medicines. Muscle loss matters because muscle tissue burns more energy at rest, supports joints, underpins balance and mobility, and is significantly harder to rebuild than to preserve. Resistance activity (bodyweight exercises, light weights, resistance bands) is the most effective available tool for holding on to it. Cardiovascular exercise contributes to heart health, blood pressure and mood, all of which are independently relevant to people managing obesity-related conditions. The practical takeaway is that exercise on Wegovy is not primarily about burning additional calories. The medicine handles appetite; the movement handles what you keep. A brisk walk three or four times a week, a couple of short resistance sessions, everyday tasks done on foot, those add up to something meaningful without requiring a significant time commitment or gym membership.
For a structured starting point, our Wegovy exercise plan guide sets out a manageable approach based on the evidence.
The titration period for Wegovy (moving through doses every four weeks from 0.25mg up toward the 2.4mg maintenance dose) can bring gastrointestinal side effects for some people: nausea, fatigue, occasional dizziness. These are typically most noticeable in the first few days after a dose step up, and they can make vigorous exercise feel unpleasant or unwise. That is entirely reasonable. There is no clinical basis for pushing through nausea on a run. Most people find that symptoms settle within days, and that timing exercise for later in the week after a dose change works better than the day immediately after. Staying well hydrated matters throughout, GI side effects combined with sweat loss can compound fatigue faster than you might expect. Intensity can be scaled gently: the best exercise is the one you can sustain, and consistency over months does more than sporadic intensity. If you're curious about what movement feels like at different stages of treatment, this overview of Wegovy and exercise covers the practical adjustments most people find helpful.
Wegovy is licensed for ongoing use, and decisions about continuing treatment are reviewed over time. What exercise builds that the medicine alone cannot is a set of physiological and behavioural changes that persist regardless of what happens to the prescription. People who maintain even moderate physical activity during weight-loss treatment tend to keep more of their lost weight over the long term. They also tend to report better energy and mood during treatment, both of which make the lifestyle changes that support the medicine easier to sustain. This is not a lecture. A question our prescribers hear regularly is whether any of this is achievable if someone has joint pain, limited mobility, or simply hasn't exercised in years. The answer is yes. Chair-based movement, water-based activity, and progressive walking are all valid starting points. The goal is consistency, not performance. If you're weighing up your options and thinking about what private Wegovy treatment involves, or exploring the full range of weight-loss treatment options, the consultation with our prescribers is a natural place to talk through what's realistic for your situation. You can also read more about the semaglutide evidence and how the medicine works before deciding. Our clinical team reviews every case individually. When you're ready, check your eligibility for a free consultation and speak with a prescriber about what a treatment plan that fits your life actually looks like.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.